MedTrace Logo

Open-Label Study for Shoulder Dislocation Using MG-1

NCT01528319 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2014-08-04

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy and safety of arthroscopic Bankart repair using MG-1 for dislocation of shoulder

Conditions

  • Shoulder Dislocation

Interventions

DEVICE

MG-1

Being embedded in the area of glenohumeral instability by arthroscopic Bankart repair method.

Sponsors & Collaborators

  • Johnson & Johnson K.K. Medical Company

    lead INDUSTRY

Principal Investigators

  • Hiroyuki Sugaya, MD, Ph.D · Funabashi Orthopaedic Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-08-31
Completion
2012-11-30

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01528319 on ClinicalTrials.gov